WebApr 18, 2024 · Case Summary. As a condition of Hikma Pharmaceuticals PLC’s $375 million acquisition of generic drug services company Custopharm, Inc., the Federal Trade … WebApr 19, 2024 · "Hikma’s acquisition of Custopharm's TCA business could have caused significant harm for patients who use TCA to treat severe skin conditions, allergies, and inflammation," Holly Vedova ...
Hikma confirms FTC preliminary approval for Custopharm
WebApr 19, 2024 · “Hikma’s acquisition of Custopharm’s TCA business could have caused significant harm for patients who use TCA to treat severe skin conditions, allergies, and inflammation,” Holly Vedova, director of the FTC’s Bureau of Competition, said in a statement. (Reporting by Diane Bartz; Editing by Aurora Ellis) WebLondon — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company and one of the largest suppliers of generic injectable medicines in the US, today … chinese new berlin wi
Hikma Pharmaceuticals Signs Agreement with Water Street to …
WebIn 2024, Hikma Pharmaceuticals acquired Custopharm to expand its product portfolio and enhance its R&D capabilities. Sector Pharmaceutical and Life Sciences; Investment Date 2015; Headquarters Carlsbad, CA; CEO William C. Larkins, Jr, PhD; View Website. Additional Pharmaceutical and Life Sciences Companies. London, 21 April 2024 – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that it has completed its acquisition of Custopharm Inc. (‘Custopharm’) from Water Street Healthcare Partners (‘Water Street’), following approval from the US Federal Trade Commission. WebSep 27, 2024 · 27 Sep, 2024 07:26 29 Jun, 2024 02:36 Hikma buys Custopharm for $375m Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt... grand prix in nashville